Differentiation of circulating monocytes into fibroblast-like cells

Darrell Pilling1, Richard H Gomer

  • 1Texas A&M University, College Station, TX, USA. dpilling@tamu.edu

Insights

Monocytes can become fibrocytes, which are implicated in fibrotic diseases. Serum amyloid P protein in blood plasma inhibits this monocyte-to-fibrocyte differentiation in vitro.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathology

Background:

  • Monocytes are key immune cells originating in bone marrow and circulating in blood.
  • These cells typically differentiate into macrophages in tissues.
  • In wound healing and fibrotic diseases, monocytes can differentiate into fibrocytes.

Purpose of the Study:

  • To investigate the potential for monocytes to differentiate into fibrocytes under specific culture conditions.
  • To identify factors that may regulate monocyte-derived fibrocytes.

Main Methods:

  • Culturing human blood monocytes or white blood cell preparations in serum-free media.
  • Observing monocyte differentiation over a 5-day period.
  • Assessing the effect of serum amyloid P on this differentiation process.

Main Results:

  • Monocytes cultured in serum-free media differentiated into fibrocytes within 5 days.
  • The presence of serum amyloid P significantly inhibited this monocyte-to-fibrocyte differentiation.
  • This suggests a regulatory role for serum amyloid P in fibrotic processes.

Conclusions:

  • Monocyte differentiation into fibrocytes can be induced in vitro.
  • Serum amyloid P acts as an inhibitor of this differentiation pathway.
  • These findings offer insights into the cellular mechanisms underlying fibrotic diseases and potential therapeutic targets.